Search

Noble E. Jarrell

Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1625, 1699, 1622, 1624, 1609
Total Applications
1419
Issued Applications
950
Pending Applications
180
Abandoned Applications
334

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16756564 [patent_doc_number] => 10975101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Ultra-potent vinca alkaloids: added molecular complexity further disrupts the tublin dimer-dimer interface [patent_app_type] => utility [patent_app_number] => 16/305357 [patent_app_country] => US [patent_app_date] => 2017-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20544 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305357 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/305357
Ultra-potent vinca alkaloids: added molecular complexity further disrupts the tublin dimer-dimer interface May 29, 2017 Issued
Array ( [id] => 17467613 [patent_doc_number] => 11274081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-15 [patent_title] => Process for the synthesis of ivacaftor [patent_app_type] => utility [patent_app_number] => 16/305280 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4002 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305280 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/305280
Process for the synthesis of ivacaftor May 25, 2017 Issued
Array ( [id] => 12346734 [patent_doc_number] => 09951081 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-04-24 [patent_title] => Chlorin e6 derivative and pharmaceutically acceptable salt thereof and process for preparing and use of the same [patent_app_type] => utility [patent_app_number] => 15/605620 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8956 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605620 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/605620
Chlorin e6 derivative and pharmaceutically acceptable salt thereof and process for preparing and use of the same May 24, 2017 Issued
Array ( [id] => 17713445 [patent_doc_number] => 11377427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Triazoles for regulating intracellular calcium homeostasis [patent_app_type] => utility [patent_app_number] => 16/304041 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11885 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304041 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/304041
Triazoles for regulating intracellular calcium homeostasis May 22, 2017 Issued
Array ( [id] => 14534329 [patent_doc_number] => 20190202786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => PYRIDINE DICARBOXAMIDE DERIVATIVES AS BROMODOMAIN INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/303211 [patent_app_country] => US [patent_app_date] => 2017-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54429 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303211 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303211
Pyridine dicarboxamide derivatives as bromodomain inhibitors May 21, 2017 Issued
Array ( [id] => 12030795 [patent_doc_number] => 20170320894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI' [patent_app_type] => utility [patent_app_number] => 15/601014 [patent_app_country] => US [patent_app_date] => 2017-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26437 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601014 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/601014
Macrocyclic quinazole derivatives and their use as MTKI May 21, 2017 Issued
Array ( [id] => 17843716 [patent_doc_number] => 11433057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Method for improving or enhancing cognition [patent_app_type] => utility [patent_app_number] => 16/097750 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7096 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097750 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097750
Method for improving or enhancing cognition May 18, 2017 Issued
Array ( [id] => 17287062 [patent_doc_number] => 11203602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-21 [patent_title] => Thioester prodrugs of macrocycles as inhibitors of histone deacetylases [patent_app_type] => utility [patent_app_number] => 16/303217 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12057 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303217 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303217
Thioester prodrugs of macrocycles as inhibitors of histone deacetylases May 17, 2017 Issued
Array ( [id] => 17452967 [patent_doc_number] => 11267812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => KRAS G12C inhibitors [patent_app_type] => utility [patent_app_number] => 16/099398 [patent_app_country] => US [patent_app_date] => 2017-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82598 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099398 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/099398
KRAS G12C inhibitors May 16, 2017 Issued
Array ( [id] => 14343295 [patent_doc_number] => 20190153620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/302043 [patent_app_country] => US [patent_app_date] => 2017-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302043 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302043
LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME May 15, 2017 Abandoned
Array ( [id] => 12057061 [patent_doc_number] => 20170333405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'CONVERGENT AND ENANTIOSELECTIVE TOTAL SYNTHESIS OF COMMUNESIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 15/592090 [patent_app_country] => US [patent_app_date] => 2017-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19494 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592090 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/592090
Convergent and enantioselective total synthesis of Communesin analogs May 9, 2017 Issued
Array ( [id] => 16343460 [patent_doc_number] => 20200308110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/098341 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098341 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098341
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors May 7, 2017 Issued
Array ( [id] => 16635232 [patent_doc_number] => 10913727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-09 [patent_title] => Modulators of the integrated stress pathway [patent_app_type] => utility [patent_app_number] => 16/098679 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129894 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098679 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098679
Modulators of the integrated stress pathway May 4, 2017 Issued
Array ( [id] => 14309473 [patent_doc_number] => 20190144440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY [patent_app_type] => utility [patent_app_number] => 16/098675 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -57 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098675
MODULATORS OF THE INTEGRATED STRESS PATHWAY May 4, 2017 Abandoned
Array ( [id] => 14309439 [patent_doc_number] => 20190144423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/098308 [patent_app_country] => US [patent_app_date] => 2017-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098308 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098308
AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF May 1, 2017 Abandoned
Array ( [id] => 14102219 [patent_doc_number] => 20190092785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/097322 [patent_app_country] => US [patent_app_date] => 2017-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097322
Enhancer of zeste homolog 2 inhibitors Apr 30, 2017 Issued
Array ( [id] => 17393331 [patent_doc_number] => 11242331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Analogs of yohimbine and uses thereof [patent_app_type] => utility [patent_app_number] => 16/097167 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 40 [patent_no_of_words] => 56671 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097167 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097167
Analogs of yohimbine and uses thereof Apr 27, 2017 Issued
Array ( [id] => 17996652 [patent_doc_number] => 11497738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Di-substituted pyrazole compounds for the treatment of diseases [patent_app_type] => utility [patent_app_number] => 16/097211 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 50340 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097211 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097211
Di-substituted pyrazole compounds for the treatment of diseases Apr 27, 2017 Issued
Array ( [id] => 19011688 [patent_doc_number] => 11918589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Medicament for treatment of multiple sclerosis [patent_app_type] => utility [patent_app_number] => 16/350297 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 44517 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 322 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16350297 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/350297
Medicament for treatment of multiple sclerosis Apr 26, 2017 Issued
Array ( [id] => 16437039 [patent_doc_number] => 20200354365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => COMPOUNDS AND METHODS FOR TARGETING HSP90 [patent_app_type] => utility [patent_app_number] => 16/095411 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095411 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095411
Compounds and methods for targeting HSP90 Apr 20, 2017 Issued
Menu